• Home
  • About Us
    Our Approach Our Team Board
  • Pipeline
  • News
  • Honor
  • Careers
  • Collaboration
  • Investor Relations
    Disclosure Contact IR
  • Contact
中文 ENG
    • Home
    • About us
      • Our Approach
      • Our Team
      • Board
    • Pipeline
    • News
    • Honor
    • Careers
    • Collaboration
    • Investor Relations
      • Disclosure
      • Contact IR
    • Contact
    • CN

COMPANY NEWS

Category Company News Enterprise Honor
2021 12

27

TYK Medicines, Inc was Awarded for two Individual “National Foreign Expert Project” by the Ministry of Science and Technology for the First Time

Discover More
2021 12

23

TY-302 capsule was approved by NMPA for combination clinical trial

Discover More
2021 11

05

TYK Medicines’ Targeted Antitumor Innovative Drug Municipal-level Science and Technology Enterprise Research and Development Center Successfully Passed the Recognition of Huzhou Science and Technology Bureau

Discover More
2021 05

24

TYK Medicines Completed a Series B+ Financing of Nearly 400 million Yuan

Discover More
2021 03

11

TYK Medicines’ third-generation EGFR inhibitor TY-9591 approved by CDE to enter pivotal Phase III clinical trial

Discover More
2020 12

30

TYK Medicines Completed the B Round of Financing and Accelerated the Promotion of the Tumor Pipeline

Discover More
<45678>
CN ENG
  • Home
  • About Us
  • Pipeline
  • News
  • Honor
  • Careers
  • Investors
  • Contact
Powered by SE

Copyright © 2019 浙江同源康 版权所有 浙ICP备19008464号